Immatics (IMTX) Cash & Equivalents (2019 - 2025)
Immatics' (IMTX) quarterly Cash & Equivalents came in at $275.6 million in Q4 2025, up 18.04% year-on-year from $233.5 million in Q4 2024, and little changed quarter-over-quarter from $276.8 million in Q3 2025.
Immatics (IMTX) Cash & Equivalents (2019 - 2025) Analysis & Trends
Immatics has disclosed Cash & Equivalents across 7 years of filings, most recently posting $275.6 million for Q4 2025.
- Cash & Equivalents for Q4 2025 came in at $275.6 million, up 18.04% year-over-year; the trailing twelve-month figure through Dec 2025 was $275.6 million (up 18.04% YoY), and the FY2025 annual result was $267.5 million, up 14.57% from the prior year.
- Cash & Equivalents came in at $275.6 million for Q4 2025 at Immatics, roughly flat from $276.8 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $290.5 million in Q2 2025 to a low of $134.1 million in Q3 2022.
- The 5-year median for Cash & Equivalents is $235.2 million (2024), against an average of $211.8 million.
- Across the five-year window, Cash & Equivalents soared 119.54% in 2021 and sank 45.21% in 2022, its largest moves.
- Immatics' Cash & Equivalents stood at $152.1 million in 2021, then fell by 0.4% to $151.5 million in 2022, then soared by 55.13% to $235.1 million in 2023, then declined by 0.68% to $233.5 million in 2024, then gained by 18.04% to $275.6 million in 2025.
- The last three Cash & Equivalents figures came in at $275.6 million (Q4 2025), $276.8 million (Q3 2025), and $290.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 1.91 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.15 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.49 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 558.94 Mn |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | 275.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 275.58 Mn |
| Sep 30, 2025 | 276.77 Mn |
| Jun 30, 2025 | 290.50 Mn |
| Mar 31, 2025 | 255.44 Mn |
| Dec 31, 2024 | 233.46 Mn |
| Sep 30, 2024 | 239.93 Mn |
| Jun 30, 2024 | 235.27 Mn |
| Mar 31, 2024 | 237.34 Mn |
| Dec 31, 2023 | 235.06 Mn |
| Sep 30, 2023 | 161.68 Mn |
| Jun 30, 2023 | 161.73 Mn |
| Mar 31, 2023 | 159.41 Mn |
| Dec 31, 2022 | 151.53 Mn |
| Sep 30, 2022 | 134.09 Mn |
| Jun 30, 2022 | 141.91 Mn |
| Mar 31, 2022 | 149.26 Mn |
| Dec 31, 2021 | 152.14 Mn |
| Sep 30, 2021 | 244.74 Mn |
| Jun 30, 2021 | 249.92 Mn |
| Mar 31, 2021 | 250.33 Mn |